Francis Caban, MD
Dermatology · Brandon, FLNPI 1518012582
Payments from drug & device makers
Across 459 payments — averaging $7091.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1.5M
- Takeda Pharmaceuticals U.S.A., Inc.$1.2M
- Sun Pharmaceutical Industries Inc.$208K
- Pfizer$138K
- Kiniksa Pharmaceuticals, Ltd.$80K
- Taro Pharmaceuticals USA, Inc.$69K
- plus $38K from 26 others
Across 8 payments — averaging $4792.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$37K
- AbbVie$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 185 | $1,531,704 |
| Takeda Pharmaceuticals U.S.A., Inc. | 55 | $1,190,199 |
| Sun Pharmaceutical Industries Inc. | 15 | $207,957 |
| Pfizer(2 entities) | 48 | $137,951 |
| Kiniksa Pharmaceuticals, Ltd. | 74 | $80,370 |
| Taro Pharmaceuticals USA, Inc. | 4 | $68,958 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $31,620 |
| Biofrontera Inc. | 4 | $2,993 |
| Merz North America, Inc. | 4 | $1,155 |
| Novartis | 12 | $332 |
| Organon | 5 | $221 |
| Regeneron Healthcare Solutions, Inc. | 8 | $205 |
| Amgen | 2 | $175 |
| Kerecis Limited | 1 | $162 |
| EPI Health, LLC | 2 | $139 |
| VYNE Pharmaceuticals Inc. | 1 | $125 |
| Phadia US Inc. | 2 | $123 |
| Boehringer Ingelheim | 4 | $101 |
| Organogenesis Inc. | 4 | $99 |
| Convatec Inc. | 4 | $88 |
| Smith+Nephew | 4 | $73 |
| Strata Skin Sciences, Inc. | 4 | $45 |
| Johnson & Johnson | 3 | $45 |
| Bioventus LLC | 2 | $38 |
| Mimedx Group, Inc. | 2 | $34 |
| Incyte Corporation | 1 | $27 |
| Almirall LLC | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| DUSA Pharmaceuticals, Inc. | 1 | $20 |
| Merck | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
How this compares
$3,255,055 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Brandon
- Michael TharpBrandon$4.7M
- Stephen LockwoodBrandon$1.2M
- Michael SherlingLake Worth$78.9M
- Seth FormanTampa$28.2M
- Thomas TaylorTampa$13.6M
- Frank DonHallandale Beach$7.5M
- Francisco FloresMiramar$6.7M
- Hector Wiltz JrMiami$6.4M
- Javier Alonso-LlamazaresCoral Gables$5.6M
- Eduardo WeissHollywood$5.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.